CABAZITAXEL DR.REDDY'S cabazitaxel 60 mg/1.5 mL concentrated injection vial

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

cabazitaxel, Quantity: 60 mg

Tilgjengelig fra:

Dr Reddys Laboratories Australia Pty Ltd

Legemiddelform:

Injection, concentrated

Sammensetning:

Excipient Ingredients: polysorbate 80; citric acid

Administreringsrute:

Intravenous Infusion

Enheter i pakken:

1

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Cabazitaxel Dr.Reddy?s in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

Produkt oppsummering:

Visual Identification: Clear yellow to brownish-yellow viscous solution.; Container Type: Multiple containers; Container Material: Glass; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Registered

Autorisasjon dato:

2018-07-23